CEREBRAL AMYLOID ANGIOPATHY AS A CAUSE OF SPONTANEOUS RECURRENT CEREBRAL HEMORRHAGE
- Authors: Fateyeva V.1, Nemenova E.1, Vorobyeva O.1
-
Affiliations:
- Issue: Vol 24, No 5 (2013)
- Pages: 40-43
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115675
- ID: 115675
Cite item
Open Access
Access granted
Abstract
Cerebral amyloid angiopathy (CAA) is a cerebral small vessel disease associated with old age. It is characterized by progressive amyloid deposition in the small and middle-sized arteries and capillaries. Sporadic amyloid angiopathy is a cause of recurrent cerebral hemorrhage and cognitive impairments in the elderly. The diagnosis and therapy of the neurological manifestations of CAA are considered.
Full Text
References
- Wardlaw J. Prediction of haematoma expansion with the CTAspotsign: Ausefulbiomarker? // The Lancet Neurology. - 2012; 11 (4): 94-295.
- Fields R. White matter in learning, cognition and psychiatric disorders // Trends Neurosci. - 2008; 31: 361-70.
- Калашникова Л. Церебральная амилоидная ангиопатия // Журн. неврол. и психиатр. им. С.С. Корсакова. - 2008; 108 (9): 86-90.
- Dierksen G., Skehan M., Khan M. et al. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy // Ann. Neurol. - 2010; 68: 545-8.
- Charidimou A., Werring D. Cerebral microbleeds: detection, mechanisms andclinical challenges // Future Neurol. - 2011; 6: 587-611.
- Rosand J., Muzikansky A., Kumar A. et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy // Ann. Neurol. - 2005; 58: 459-62.
- Zhu Y., Chabriat H., Godin O. et al. Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging // J. Neurol. Publ. Online First: 30 August 2011. doi: 10.1007/s00415-011-6218-3.
- Eckman M., Wong L., Soo Y. et al. Patient-specific decision-making for warfarin therapy in nonvalvular atrial fibrillation: how will screening with genetics andimaging help? // Stroke. - 2008; 39: 3308-15.
- Charidimou A., Werring D. Cerebral microbleeds: detection, mechanisms and clinical challenges // Future Neurol. - 2011; 6: 587-611.
- Gervais F., Paquette J., Morissette C. et al. Targeting soluble Abeta peptide withtramiprosate for the treatment of brain amyloidosis // Neurobiol. Aging. - 2007; 28: 537-47.
Supplementary files
